C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2001
11/06/2001	US6312936 Enzymatic polypeptide for use in the treatment of animal feeds and textiles
11/06/2001	US6312933 Carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme
11/06/2001	US6312923 Method for expression of heterologous proteins in yeast
11/06/2001	US6312922 Complementary DNAs
11/06/2001	US6312916 Mutant polypeptide; for use in reduction of inteference associated with immunoassays
11/06/2001	US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals
11/06/2001	US6312890 Partial intron sequence of von hippel-lindau (VHL) disease gene and its use in diagnosis of disease
11/06/2001	US6312693 Antibodies against human CD40
11/06/2001	US6312688 Tyrosine-phosphatase-related protein
11/06/2001	US6311546 Biofouling monitor and methods to monitor or detect biofouling
11/01/2001	WO2001081623A2 Neuronally expressed protein having apoptotic activity, and use thereof
11/01/2001	WO2001081603A2 Trophic conversion of obligate phototrophic algae through metabolic engineering
11/01/2001	WO2001081599A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001	WO2001081597A1 Method for producing recombinant proteins by gram-negative bacteria
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	WO2001081580A1 Origin of replication in the hyperthermophilic pyrococcus archea and its applications
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081573A1 Edg8 receptor, its preparation and use
11/01/2001	WO2001081564A2 Method for producing dna encoding polypeptides that are composed of several sections, and for producing polypeptides by expressing the dna thus obtained
11/01/2001	WO2001081563A1 Novel (r)-2-hydroxy-3-phenylpropionate (d-phenyllactate) dehydrogenase and gene encoding the same
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081560A1 Glucuronofucan sulfate
11/01/2001	WO2001081548A1 Novel cell systems having specific interaction of peptide binding pairs
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081425A1 Use of a secondary cell wall polymer of procaryotic microorganisms
11/01/2001	WO2001081423A1 Antibodies against native gp96, production and use thereof
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081413A2 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001	WO2001081412A2 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
11/01/2001	WO2001081409A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/01/2001	WO2001081408A2 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	WO2001081405A2 Methods and compositions for the prevention and treatment of anemia
11/01/2001	WO2001081400A1 Nk-2 homeobox transcription factor
11/01/2001	WO2001081387A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001	WO2001081380A2 Immunogenic pneumococcal protein and vaccine compositions thereof
11/01/2001	WO2001081379A2 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2001081377A2 Integrin/adhesion antagonists
11/01/2001	WO2001081376A2 Apo-ai/aii peptide derivatives
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001080883A1 Bispecific molecules and uses thereof
11/01/2001	WO2001080880A2 Apoptotic agents
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080810A2 Chondroitin synthase gene and methods of making and using same
11/01/2001	WO2001080663A1 Animal feed additives and method of producing the same
11/01/2001	WO2001042436A3 Genes involved in cyclododecanone degradation pathway
11/01/2001	WO2001038484A3 Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001034807A3 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r¿2?
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001032866A3 Hybrid adaptor receptors
11/01/2001	WO2001023578A9 The gene cluster involved in aclacinomycin biosynthesis, and its use for genetic engineering
11/01/2001	WO2001009176A3 Mammalian cytokines; related reagents
11/01/2001	WO2000043523A3 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate)
11/01/2001	WO2000040607A3 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2000024780A9 Compositions and methods for treating polycystic kidney disease
11/01/2001	US20010036910 Detergent additive, papermaking
11/01/2001	US20010036672 Miniaturization
11/01/2001	US20010036665 Method of preparing cryogenically preserved adherent cell containing plate for tissue culture applications
11/01/2001	US20010036662 Genetic engineered nucleotide sequence
11/01/2001	US20010036660 Reacting a a-keto acid with methylamine
11/01/2001	US20010036659 Culture product; forming ethanol
11/01/2001	US20010036658 Culture media for growing spirochetes
11/01/2001	US20010036655 Vaccine
11/01/2001	US20010036654 Transgenic plant extract
11/01/2001	EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	CA2690018A1 Methods and compositions for the prevention and treatment of anemia
11/01/2001	CA2417011A1 Method for producing dna encoding polypeptides that are composed of several sections, and for producing polypeptides by expressing the dna thus obtained
11/01/2001	CA2407639A1 Using the secondary cell wall polymers of prokaryotic microorganisms
11/01/2001	CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001	CA2407455A1 Immunogenic pneumococcal protein and vaccine compositions thereof
11/01/2001	CA2407449A1 Novel compounds
11/01/2001	CA2407382A1 Novel cell systems having specific interaction of peptide binding pairs
11/01/2001	CA2407352A1 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	CA2407167A1 Thrombopoietin receptor modulating peptide
11/01/2001	CA2407114A1 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	CA2407086A1 Integrin/adhesion antagonists
11/01/2001	CA2407084A1 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001	CA2407083A1 Apo-ai/aii peptide derivatives
11/01/2001	CA2407081A1 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
11/01/2001	CA2407077A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/01/2001	CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	CA2406839A1 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	CA2406725A1 Edg8 receptor, its preparation and use
11/01/2001	CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	CA2406264A1 Protein phosphatases
11/01/2001	CA2405985A1 Nk-2 homeobox transcription factor
11/01/2001	CA2405983A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001	CA2405961A1 Bispecific molecules and uses thereof
11/01/2001	CA2405138A1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001	CA2404900A1 Trophic conversion of obligate phototrophic algae through metabolic engineering
10/2001
10/31/2001	EP1149919A2 Genes related to biosynthesis of ML-236B
10/31/2001	EP1149918A1 Process for the oxidation of hydrocarbons by use of microorganisms
10/31/2001	EP1149912A2 Polyhydroxyalkanoate synthase and gene encoding the same
10/31/2001	EP1149911A2 Amino acid producing strains belonging to the genus Escherichia and method for producing amino acid
10/31/2001	EP1149906A1 Thrombopoietin receptor modulating peptide
10/31/2001	EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof

1 ... 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 ... 1489